Top Message
Top Message
Back to Home Page  |  Settings   |  Sign In
Web Education
Viewing 1-1 of 1 total results
Regulatory Focus™ | RAPS
The US Food and Drug Administration (FDA) on Wednesday said it plans to withdraw the approval of 249 abbreviated new drug applications (ANDAs) after their manufacturers repeatedly failed to submit annual reports for the generic drugs.
https://www.raps.org/news-and-articles
Average Rating (0 votes)